Essiac: systematic review by the natural standard research collaboration.

Catherine Ulbricht, Wendy Weissner, Sadaf Hashmi, Tracee Rae Abrams, Cynthia Dacey, Nicole Giese, Paul Hammerness, Dana A Hackman, Jenny Kim, Audrey Nealon, Ruslan Voloshin
{"title":"Essiac: systematic review by the natural standard research collaboration.","authors":"Catherine Ulbricht,&nbsp;Wendy Weissner,&nbsp;Sadaf Hashmi,&nbsp;Tracee Rae Abrams,&nbsp;Cynthia Dacey,&nbsp;Nicole Giese,&nbsp;Paul Hammerness,&nbsp;Dana A Hackman,&nbsp;Jenny Kim,&nbsp;Audrey Nealon,&nbsp;Ruslan Voloshin","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>The objective of this study was to evaluate the scientific evidence on the safety and efficacy of Essiac. This review serves as a clinical support tool. Electronic searches were conducted in 10 databases, 20 additional journals (not indexed in common databases), and bibliographies from 50 selected secondary references. No restrictions were placed on the language or quality of the publications. Standardized inclusion and exclusion criteria were used for selection. A review of the literature on Essiac and essiac formulations showed a lack of high-quality clinical trials to substantiate any of Essiac's traditional uses. Weak evidence from preclinical, animal, and laboratory data warranted a discussion regarding Essiac's use for cancer, but the results are inconclusive. Several other essiac preparations are noted in the literature, adding confusion to the exact formula and its proposed benefits. In general, there is a lack of both safety and efficacy data for Essiac and essiac formulations. Well-designed trials testing Essiac or individual herbal components are necessary to make firm recommendations.</p>","PeriodicalId":87409,"journal":{"name":"Journal of the Society for Integrative Oncology","volume":"7 2","pages":"73-80"},"PeriodicalIF":0.0000,"publicationDate":"2009-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the Society for Integrative Oncology","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

The objective of this study was to evaluate the scientific evidence on the safety and efficacy of Essiac. This review serves as a clinical support tool. Electronic searches were conducted in 10 databases, 20 additional journals (not indexed in common databases), and bibliographies from 50 selected secondary references. No restrictions were placed on the language or quality of the publications. Standardized inclusion and exclusion criteria were used for selection. A review of the literature on Essiac and essiac formulations showed a lack of high-quality clinical trials to substantiate any of Essiac's traditional uses. Weak evidence from preclinical, animal, and laboratory data warranted a discussion regarding Essiac's use for cancer, but the results are inconclusive. Several other essiac preparations are noted in the literature, adding confusion to the exact formula and its proposed benefits. In general, there is a lack of both safety and efficacy data for Essiac and essiac formulations. Well-designed trials testing Essiac or individual herbal components are necessary to make firm recommendations.

分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Essiac:由自然标准研究合作进行的系统评价。
本研究的目的是评估Essiac安全性和有效性的科学证据。本综述可作为临床支持工具。在10个数据库、20个额外期刊(未在共同数据库中编入索引)和50个选定的次要参考文献的书目中进行了电子检索。对出版物的语言或质量没有任何限制。采用标准化的纳入和排除标准进行选择。对Essiac和Essiac制剂的文献回顾显示,缺乏高质量的临床试验来证实Essiac的任何传统用途。来自临床前、动物和实验室数据的微弱证据证明了对Essiac用于癌症的讨论,但结果尚无定论。在文献中提到了其他几种乙胺制剂,增加了对确切配方及其建议益处的混淆。总的来说,Essiac和Essiac制剂缺乏安全性和有效性数据。有必要对Essiac或个别草药成分进行精心设计的试验,以提出坚定的建议。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
GINKGO, GINKGO BILOBA Yoga for Pain and Anxiety in Pediatric Hematology- Oncology Patients: Case Series and Review of the Literature Evaluation of the hepatic metabolism and antitumor activity of noni juice (Morinda citrifolia L.) in combination with chemotherapy Not soy simple. Team science of nursing, engineering, statistics, and practitioner in the development of a robotic reflexology device.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1